Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
EGTX.STthis companyEgetis Therapeutics AB (publ)	SEK 11.12	-5.74×	5.81×	31.51×	-5.36×	-144.1%	19.9%	-555.9%	-548.9%	-101.1%	-79.2%	-13.7%	0.27×	0.36×	-15.28×	1.05×	0.0%	5	4.55	1	C-
DMYD-B.STDiamyd Medical AB (publ)	SEK 0.98	-0.58×	0.61×	310.44×	0.62×	98.3%	-478.8%	-54562.9%	-53583.4%	-104.9%	-78.6%	-132.6%	0×	1.21×	-73.88×	9.08×	0.0%	3	-0.68	2	B-
IBT-B.STInfant Bacterial Therapeutics AB (publ)	SEK 72.80	-10.43×	6.46×	0×	-7.87×	-89.1%	0.0%	0.0%	0.0%	-61.9%	-58.8%	-10.6%	0×	2.11×	0×	2.72×	0.0%	2	-1.32	1	D+
VICO.STVicore Pharma Holding AB (publ)	SEK 10.82	-5.68×	2.47×	710.16×	-4.47×	-73.9%	100.0%	-11905.8%	-12509.1%	-43.6%	-41.2%	-13.9%	0×	1.21×	-9.03×	10.31×	0.0%	1	20.24	1	C-
Peer median	—	-5.68×	2.47×	310.44×	-4.47×	-73.9%	0.0%	-11905.8%	-12509.1%	-61.9%	-58.8%	-13.9%	0×	1.21×	-9.03×	9.08×	0.0%	2	-0.68	1	—